Approximately 39 million people in the U.S. have migraine and up to 1 million have cluster headache, Amneal noted. There are limited treatment options for cluster headache.

Explore how migraine contributes to memory loss and brain fog. Discover causes, effects on cognition, medication risks, and management strategies for those with migraine.

Learn about common-over-the-counter (OTC) treatments for migraine attacks, including acetaminophen and NSAIDs such as aspirin ...

The monoclonal antibody eptinezumab, which targets calcitonin gene-related peptide, has shown migraine preventive effects starting the day following infusion and acceptable safety and tolerability in ...

People with chronic migraine felt their logistic, emotional, and financial support of their families all suffered because of their migraine disease.

Teva Pharmaceutical has reported the final analysis of the PEARL Phase IV migraine prevention trial of the anti-calcitonin gene-related peptide (CGRP) monoclonal antibody, Ajovy (fremanezumab), in ...

mMR is associated with better treatment response than gepants in patients with migraine who previously had an inadequate response to gepants.

No migraine products have officially been approved for use in children. Other types of drugs, including opioids and barbiturates, are sometimes prescribed off-label for migraine treatment.

Two drugs (valproate and topiramate) are FDA-approved for this indication. Sodium valproate is approved for migraine prophylaxis; however, the teratogenic potential of the compound limits its use.

Many of those options have been identified in just the past ten years or so—meaning even a longtime migraine sufferer could find relief.

Lundbeck advances leadership in migraine with new data at the American Headache Society 67th Annual Scientific MeetingIn a post-hoc analysis of the DELIVER trial, interictal periods were longer ...

New research reveals that sleep deprivation alters how the brain processes pain in people with migraines.